Glaukos‘s patent involves drug delivery devices for treating ocular disorders with controlled drug release into different ocular spaces. The ocular implant includes an outer shell, drug barriers, release elements, and a flange to prevent tissue obstruction. This innovation allows targeted and controlled drug administration within the eye. GlobalData’s report on Glaukos gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Glaukos, Customized implants was a key innovation area identified from patents. Glaukos's grant share as of February 2024 was 41%. Grant share is based on the ratio of number of grants to total number of patents.
Ocular implant for controlled drug delivery
A drug delivery ocular implant has been granted a patent (Publication Number: US11925578B2) with a unique design aimed at efficient drug delivery within the eye. The implant comprises an outer shell with an interior chamber divided by a drug barrier into two subchambers, each containing a different drug. The release of these drugs is controlled by specific membranes within the chamber, allowing for targeted drug delivery. Additionally, the implant features a flange to prevent tissue obstruction of the inlet, ensuring consistent drug release.
Furthermore, the ocular implant includes elements such as seal members, retainers, and specific drug components like prostaglandin analogs and vasodilators, enhancing its functionality. The design also incorporates features like impermeable drug barriers, equal volume subchambers, and semi-permeable membranes for optimized drug release. With the potential to deliver drugs like nitric oxide precursors and generate nitric oxide within the eye, this patented ocular implant represents a significant advancement in the field of drug delivery systems for ocular conditions, offering a promising solution for targeted and effective treatment.
To know more about GlobalData’s detailed insights on Glaukos, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
